Natàlia García‐Reyero

Adverse Outcome Pathway (AOP) Development I: Strategies and Principles

Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero et al. · Toxicological Sciences · 2014 · 711 citations · Full text

Pharmacy, Toxicology, Mechanisms Of Toxicity +15

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)

Knut Erik Tollefsen, Stefan Scholz, M Cronin et al. · Regulatory Toxicology and Pharmacology · 2014 · 371 citations · Full text

Pharmacy, Toxicology, Regulatory Science +16

Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study

Sheng Li, Scott Tighe, Charles M. Nicolet et al. · Nature Biotechnology · 2014 · 261 citations · Full text

Life Sciences, Biology, Molecular Biology +13

Adverse Outcome Pathway Development II: Best Practices

Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero et al. · Toxicological Sciences · 2014 · 257 citations · Full text

Pharmacy, Systems Biology, Toxicology +17

Endocrine disrupting chemicals in fish: Developing exposure indicators and predictive models of effects based on mechanism of action

Gerald T. Ankley, David C. Bencic, Michael S. Breen et al. · Aquatic Toxicology · 2009 · 256 citations

Veterinary Medicine, Environmental Sciences, Toxicology +14